Keyphrases
Transjugular Intrahepatic Portosystemic Shunt
100%
Liver Transplantation
67%
Group Studies
60%
Liver
42%
Therapeutic Approaches
35%
Portal Hypertension
33%
Yttrium-90 Radioembolization
20%
Right Atrial Pressure
20%
Intestinal Transplantation
20%
MELD Score
19%
Hepatocellular Carcinoma
19%
Liver Transplant Recipients
18%
Biliary Stricture
17%
Post-liver Transplant
16%
Hepatic Hydrothorax
15%
Confidence Interval
15%
Covered Stent
15%
Controlled Expansion
15%
Portal Vein Thrombosis
15%
Cirrhosis
14%
Variceal Bleeding
13%
Renal Disease
13%
Transplantation
13%
Chronic Portal Vein Thrombosis
13%
Stent
13%
Hepatic Encephalopathy
12%
Procedural
12%
Cholangiography
12%
Biliary Intervention
12%
Patient Selection
12%
MELD-Na
12%
Adverse Events
12%
Bilioenteric Anastomosis
12%
Refractory Ascites
12%
Heart Failure
11%
Portal Hypertensive
11%
Multiorgan Transplantation
11%
Non-cirrhotic
11%
Hypertensive Complications
10%
Ascites
10%
Nonalcoholic Steatohepatitis
10%
Gastrointestinal Bleeding
10%
Type 1 Diabetes Mellitus (T1DM)
10%
Transplant Center
10%
Subdistribution Hazard Ratio
10%
Endoscopy
10%
Care Partner
10%
Practice-based
10%
Hepatitis C Treatment
10%
Intrahepatic Portosystemic Shunt
10%
Medicine and Dentistry
Transjugular Intrahepatic Portosystemic Shunt
100%
Liver Transplantation
51%
Portal Hypertension
35%
Liver Graft
28%
Hepatocellular Carcinoma
28%
Yttrium 90
25%
Ascites
22%
Radioembolization
22%
Shunt Creation
22%
Endoscopy
22%
Nonalcoholic Fatty Liver
20%
Heart Right Atrium Pressure
20%
Intestinal Transplantation
20%
Bleeding
18%
Cholestasis
17%
Hepatic Encephalopathy
16%
Adverse Event
15%
Retrospective Study
15%
Hydrothorax
15%
Liver Cirrhosis
15%
Overall Survival
14%
Portal Vein Thrombosis
14%
Embolization
14%
Portosystemic Anastomosis
13%
Neoplasm
12%
Bile Duct Bypass
12%
Cholangiography
12%
Liver Disease
12%
Platelet
11%
Congestive Heart Failure
11%
Hepatic Portal Vein
11%
Hazard Ratio
11%
Observational Study
11%
Gastrointestinal Bleeding
10%
Prospective Study
10%
Diabetes Mellitus
10%
Organ Donor
10%
VIPoma
10%
Mammalian Target of Rapamycin Inhibitor
10%
Endoscopic Retrograde Cholangiopancreatography
10%
COVID-19
10%
Portal Vein Obstruction
10%
Chronic Diarrhea
10%
Mesenteric Vein Thrombosis
10%
Acute on Chronic Liver Failure
10%
Multivisceral Transplantation
10%
Chronic Liver Disease
10%
Aneurysm
10%
Recanalization
10%
Liver Pathology
10%
